TomEnterprise AB's Form 4 filing
DiaMedica Therapeutics Inc. (DMAC) · filed Dec 6, 2022
- Accession no.
- 0001567619-22-021344
- Filed
- Dec 6, 2022, 3:19 PM ET
- Trade date
- Dec 2, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $3.53M. Open-market sales total $3.53M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| TomEnterprise ABCIK 0001887435 | 10% Owner |
| Von Koch ThomasCIK 0001938915 | 10% Owner |
| TomEnterprise Private ABCIK 0001956782 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Common Shares | SSaleDisposed | −2,855,847 | $1.24 | −$3,526,971.05 | 0 | Indirect | |
| Dec 2, 2022 | Common Shares | PPurchaseAcquired | +2,855,847 | $1.24 | +$3,526,971.05 | 2,855,847 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.